Three-dimensional genome organization linked to molecular changes in Alzheimer's disease
Researchers using single-cell analysis techniques have identified alterations in three-dimensional genome architecture as a previously underappreciated component of Alzheimer's disease pathology. The study combined multi-omics approaches and artificial intelligence modeling to examine how chromatin folding and gene activity patterns differ between healthy brain tissue and tissue from individuals with Alzheimer's disease. These findings suggest that disruptions in how DNA physically organizes within cells may contribute to the disease's development alongside the well-known accumulation of amyloid-beta plaques and tau tangles.
The three-dimensional folding of DNA within brain cells has long been recognized as important for controlling which genes are active, but its role in Alzheimer's disease was largely unexplored until now. Researchers examined postmortem brain tissue from both healthy individuals and those with Alzheimer's disease, discovering that the normal compartmentalization of the genome—where active and inactive DNA regions maintain distinct boundaries—becomes disrupted in diseased tissue. This architectural breakdown correlated with reduced overall gene activity in affected cells.
The investigation employed advanced techniques to map both the physical structure of DNA and patterns of gene expression simultaneously at the single-cell level, then used artificial intelligence to model how these structural changes might influence disease-related gene activity patterns. The analysis revealed that disrupted genome organization was associated with altered function in cellular networks governing neural communication, energy metabolism, immune responses, and aging processes in brain cells.
These findings could reshape how scientists approach Alzheimer's research by highlighting a previously overlooked dimension of the disease alongside protein accumulation. If genome architecture disruptions prove to be causative rather than consequential, this may open new therapeutic avenues targeting DNA organization in brain cells. The discovery could benefit millions affected by or at risk for Alzheimer's, though researchers emphasize that further investigation is needed to establish whether these architectural changes drive disease progression or result from it.